Joseph Vazzano
2023 - Abeona Therapeutics
In 2023, Joseph Vazzano earned a total compensation of $1.5M as Chief Financial Officer at Abeona Therapeutics, a 63% increase compared to previous year.
Compensation breakdown
| Bonus | $235,333 |
|---|---|
| Non-Equity Incentive Plan | $232,320 |
| Salary | $440,000 |
| Stock Awards | $571,889 |
| Other | $13,200 |
| Total | $1,492,742 |
Vazzano received $571.9K in stock awards, accounting for 38% of the total pay in 2023.
Vazzano also received $235.3K in bonus, $232.3K in non-equity incentive plan, $440K in salary and $13.2K in other compensation.
Rankings
In 2023, Joseph Vazzano's compensation ranked 789th out of 2,918 executives tracked by ExecPay. In other words, Vazzano earned more than 73.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 789 out of 2,918 | 73rd |
Division Manufacturing | 466 out of 1,608 | 71st |
Major group Chemicals And Allied Products | 317 out of 901 | 65th |
Industry group Drugs | 309 out of 864 | 64th |
Industry Pharmaceutical Preparations | 206 out of 622 | 67th |
Source: SEC filing on November 12, 2024.
Vazzano's colleagues
We found two more compensation records of executives who worked with Joseph Vazzano at Abeona Therapeutics in 2023.
News
Abeona Therapeutics CEO Vishwas Seshadri's 2023 pay jumps 90% to $2.8M
March 19, 2024
Abeona Therapeutics CEO Vishwas Seshadri's 2022 pay slips 4% to $1.5M
April 13, 2023
AVENUE THERAPEUTICS CEO Lucy Lu's 2021 pay jumps 144% to $1.1M
November 18, 2022
AVENUE THERAPEUTICS CEO Lucy Lu's 2020 pay falls 31% to $443K
November 23, 2021
AVENUE THERAPEUTICS CEO Lucy Lu's 2019 pay falls 60% to $640K
April 29, 2020
AVENUE THERAPEUTICS CEO Lucy Lu's 2018 pay falls 22% to $1.6M
April 30, 2019